# Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

> **NCT02019576** · PHASE2 · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 38 (actual)

## Conditions studied

- Clear Cell Metastatic Renal Cell Carcinoma

## Interventions

- **RADIATION:** Stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT02019576
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2021-02-16
- **Final completion:** 2021-03-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019576, "Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02019576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*